Bibliography
- Chouinard G. Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. J Clin Psychiatry 2004;65:7-12
- Sheehan DV, Sheehan KH, Raj BA. The speed of onset of action of alprazolam-XR compared to alprazolam-CT in panic disorder. Psychopharmacol Bull 2007;40:63-81
- Kita A, Furukawa K. Involvement of neurosteroids in the anxiolytic-like effects of AC-5216 in mice. Pharmacol Biochem Behav 2008;89:171-8
- Lankford DA, Corser BC, Zheng YP, et al. Effect of gaboxadol on sleep in adult and elderly patients with primary insomnia: results from two randomized, placebo-controlled, 30-night polysomnography studies. Sleep 2008;31:1359-70
- Thomson F, Craighead M. Innovative approaches for the treatment of depression: targeting the HPA axis. Neurochem Res 2008;33:691-707
- Montgomery SA, Baldwin DS, Blier P, et al. Which antidepressants have demonstrated superior efficacy? A review of the evidence. Int Clin Psychopharmacol 2007;22:323-9
- Yankner BA, Lu T. Amyloid beta-protein toxicity and the pathogenesis of Alzheimer's disease. J Biol Chem 2008 [Epub ahead of print]
- Becker RE, Greig NH, Giacobini E. Why do so many drugs for Alzheimer's disease fail in development? Time for new methods and new practices? J Alzheimers Dis 2008;15:303-25
- Butera JA. Current and emerging targets to treat neuropathic pain. J Med Chem 2007;50:2543-6